The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The role of p53 in determining sensitivity to radiotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, p53-induced apoptosis in radiosensitive tissues can account for the damaging side effects associated with genotoxic chemotherapies or radiation therapies (Gudkov and Komarova, 2003).”
From p53 at a glance (2010) · cites this paper as Gudkov and Komarova, 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G. M., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35019501 · Cited by 1,511
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Deveraux, Q. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,388
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,283
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Self-citationOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Santana, P., Peña, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1996) · Cell · doi:10.1016/s0092-8674(00)80091-4 · Cited by 797
Vousden, K. H. (2000) · Cell · doi:10.1016/s0092-8674(00)00171-9 · Cited by 790
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
High levels of p53 protein in UV-irradiated normal human skin.
Hall, P. A., Ph, M., Hd, M., Dover, R., & Lane, D. P. (1993) · PubMed · Cited by 673
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664
Radiation response of the central nervous system
Schultheiss, T. E., Kun, L. E., Ang, K. K., & Stephens, L. C. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00655-5 · Cited by 653
Mechanisms of p53-dependent apoptosis
Schuler, M., & Green, D. R. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290684 · Cited by 641
Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, A., Lane, D. P., & Hall, P. A. (1994) · PubMed · Cited by 560
Molecular Genetics of Circadian Rhythms in Mammals
King, D. P., & Takahashi, J. S. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.713 · Cited by 551
(1999) · PubMed · Cited by 546
Bernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
ATAXIA-TELANGIECTASIA AND THE NIJMEGEN BREAKAGE SYNDROME: Related Disorders But Genes Apart
Shiloh, Y. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.635 · Cited by 481
Aladjem, M. I., Spike, B. T., Rodewald, L. W., Hope, T. J., Klemm, M., Jaenisch, R., & Wahl, G. M. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70061-2 · Cited by 442
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription
Takai, H., Naka, K., Okada, Y., Watanabe, M., Harada, N., Saito, S., Anderson, C. W., Appella, E., Nakanishi, M., Suzuki, H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf506 · Cited by 436
Dasika, G. K., Lin, S.-C. J., Zhao, S., Sung, P., Tomkinson, A., & Lee, E. Y.-H. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203283 · Cited by 427
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
Rogel, A., Popliker, M., Webb, C. G., & Oren, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2851 · Cited by 378
The evolution of diverse biological responses to DNA damage: insights from yeast and p53
Wahl, G. M., & Carr, A. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-e277 · Cited by 376
Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z., Lee, S. W., & Aaronson, S. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2180 · Cited by 374
Interleukin 1 is a radioprotector.
Neta, R., Douches, S., & Oppenheim, J. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2483 · Cited by 371
Ford, J. M., & Hanawalt, P. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28073 · Cited by 358
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
Cell-specific Induction of Apoptosis by Microinjection of Cytochrome c
Li, F., Srinivasan, A., Wang, Y., Armstrong, R. C., Tomaselli, K. J., & Fritz, L. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30299 · Cited by 347
(1993) · PubMed · Cited by 323
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Hawkins, D. S., Demers, G. W., & Galloway, D. A. (1996) · PubMed · Cited by 297
Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation
Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J. B., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64926-7 · Cited by 285
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
Seo, Y. R., Kelley, M. R., & Smith, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212319799 · Cited by 280
Evidence of a Novel Event during Neuronal Death
Deshmukh, M., & Johnson, E. M. (1998) · Neuron · doi:10.1016/s0896-6273(00)80587-5 · Cited by 279
Genetic analysis of chemoresistance in primary murine lymphomas
Schmitt, C. A., Rosenthal, C. T., & Lowe, S. W. (2000) · Nature Medicine · doi:10.1038/79542 · Cited by 278
V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
Guidos, C. J., Williams, C. J., Grandal, I., Knowles, G., Huang, M. T., & Danska, J. S. (1996) · Genes & Development · doi:10.1101/gad.10.16.2038 · Cited by 275
Komarova, E. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1391 · Cited by 273
Self-citationClarke, A. R., Gledhill, S., Ml, H., Bird, C. C., & Wyllie, A. (1994) · PubMed · Cited by 267
Sensing and responding to DNA damage
Lowndes, N. F., & Murguia, J. R. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00050-7 · Cited by 266
Neta, R., Oppenheim, J. J., & Douches, S. D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.1.108 · Cited by 260
ATM, a central controller of cellular responses to DNA damage
Khanna, K., Lavin, M., Jackson, S., & Mulhern, T. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400874 · Cited by 252
p53-dependent apoptosis suppresses radiation–induced teratogenesis
Norimura, T., Nomoto, S., Katsuki, M., Gondo, Y., & Kondo, S. (1996) · Nature Medicine · doi:10.1038/nm0596-577 · Cited by 247
Midgley, C. A., Owens, B., Briscoe, C. V., Thomas, D. B., Lane, D. P., & Hall, P. A. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.5.1843 · Cited by 235
Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., & Leder, P. (1997) · Nature Genetics · doi:10.1038/ng0897-397 · Cited by 226
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
Brachman, D. G., Beckett, M., Graves, D., Haraf, D. J., Vokes, E. E., & Weichselbaum, R. R. (1993) · PubMed · Cited by 222
Interaction of p53 with the Human Rad51 Protein
Buchhop, S., Gibson, M. K., Wang, X. W., Wagner, P., Sturzbecher, H.-W., & Harris, C. C. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.19.3868 · Cited by 215
Stress signals for apoptosis: ceramide and c-Jun kinase
Basu, S., & Kolesnick, R. (1998) · Oncogene · doi:10.1038/sj.onc.1202570 · Cited by 211
Barcellos‐Hoff, M. H. (1993) · PubMed · Cited by 209
The p53 response to ionising radiation in adult and developing murine tissues.
MacCallum, D. E., Hupp, T. R., Midgley, C. A., Stuart, D., Campbell, S. J., Harper, A., Walsh, F. S., Wright, E. G., Balmain, A., Lane, D. P., et al. (1996) · PubMed · Cited by 200
Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation.
Campbell, C., Quinn, A., Angus, B., Farr, P. M., & Rees, J. L. (1993) · PubMed · Cited by 195
Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53
Albrechtsen, N., Dornreiter, I., Grosse, F., Kim, E., Wiesmüller, L., & Deppert, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202952 · Cited by 182
Cell Kinetics and Radiation Biology
Denekamp, J. (1986) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553008514552591 · Cited by 177
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168
p53 regulation of DNA excision repair pathways
Smith, M. L. (2002) · Mutagenesis · doi:10.1093/mutage/17.2.149 · Cited by 162
Multiple Pathways for Apoptotic Nuclear Fragmentation
Dini, L., Coppola, S., Ruzittu, M. T., & Ghibelli, L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0089 · Cited by 159
West, C. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143716 · Cited by 159
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53
Komarova, E. A., Diatchenko, L. B., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., & Gudkov, A. V. (1998) · Oncogene · doi:10.1038/sj.onc.1202303 · Cited by 140
Self-citationTime and Dose Relationships in Radiation Biology as Applied to Radiotherapy
Howard, A. (1971) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007114550291 · Cited by 139
Burns, T. F., Bernhard, E. J., & El‐Deiry, W. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204484 · Cited by 138
Biological Factors Influencing Optimum Fractionation in Radiation Therapy
Fowler, J. F. (2001) · Acta Oncologica · doi:10.1080/02841860152619124 · Cited by 130
Different impact of p53 and p21 on the radiation response of mouse tissues
Komarova, E. A., Christov, K. T., Faerman, A., & Gudkov, A. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203717 · Cited by 126
Self-citationRosen, E. M., Fan, S., Rockwell, S., & Goldberg, I. D. (1999) · Cancer Investigation · doi:10.1080/07357909909011718 · Cited by 123
Hasegawa, M., Zhang, Y., Niibe, H., Terry, N. H. A., & Meistrich, M. L. (1998) · Radiation Research · doi:10.2307/3579959 · Cited by 123
Molecular cloning of the human DNA excision repair gene ERCC-6.
Troelstra, C., Odijk, H., de Wit, J., Westerveld, A., Thompson, L. H., Bootsma, D., & Hoeijmakers, J. H. J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5806 · Cited by 120
Pre-TCR Signaling and Inactivation of p53 Induces Crucial Cell Survival Pathways in Pre-T Cells
Haks, M. C., Krimpenfort, P., van den Brakel, J. H. N., & Kruisbeek, A. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80084-9 · Cited by 119
Radioprotection of mice by recombinant rat stem cell factor.
Zsebo, K. M., Smith, K. A., Hartley, C. A., Greenblatt, M., Cooke, K. R., Rich, W., & McNiece, I. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9464 · Cited by 118
Offer, H., Erez, N., Zurer, I., Tang, X., Milyavsky, M., Goldfinger, N., & Rotter, V. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.1025 · Cited by 113
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 109
Brash, D. E., & Havre, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232574399 · Cited by 108
Jordan, B. F., Grégoire, V., Demeure, R., Sonveaux, P., Féron, O., O’Hara, J. A., Vanhulle, V. P., Delzenne, N. M., & Gallez, B. (2002) · PubMed · Cited by 107
Tumour suppressors: A developing role for p53?
Hall, P. A., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70074-5 · Cited by 101
p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.
Offer, H., Zurer, I., Bánfalvi, G., Rehak, M., Falcovitz, A., Milyavsky, M., Goldfinger, N., & Rotter, V. (2001) · PubMed · Cited by 98
p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
Tron, V. A., Trotter, M. J., Tang, L., Krajewska, M., Reed, J. C., Ho, V. C., & Li, G. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65600-3 · Cited by 97
Bcl-2 Mediates Chemoresistance in Matched Pairs of Primary Eμ-myc Lymphomas in Vivo
Schmitt, C. A., & Lowe, S. W. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0372 · Cited by 97
Radiation-induced apoptosis in the adult central nervous system is p53-dependent
Chow, B., Li, Y., & Wong, C. S. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400704 · Cited by 96
Fas Is Involved in the p53-Dependent Apoptotic Response to Ionizing Radiation in Mouse Testis1
Embree-Ku, M., Venturini, D. S., & Boekelheide, K. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.5.1456 · Cited by 93
Unraveling DNA Repair in Human: Molecular Mechanisms and Consequences of Repair Defect
Tuteja, N. K., & Tuteja, R. (2001) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/20014091074192 · Cited by 85
Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.
Falette, N., Paperin, M.-P., Treilleux, I., Gratadour, A.-C., Peloux, N., Mignotte, H., Tooke, N., Löfman, E., Inganäs, M., Bremond, A. G., et al. (1998) · PubMed · Cited by 82
Loss of atm radiosensitizes multiple p53 null tissues.
Westphal, C. H., Hoyes, K. P., Canman, C. E., Huang, X., Kastan, M. B., Hendry, J. H., & Leder, P. (1998) · PubMed · Cited by 81
Song, S., & Lambert, P. F. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65215-7 · Cited by 71
p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.
Kemp, C. J., Sun, S., & Gurley, K. E. (2001) · PubMed · Cited by 65
Chronobiology of the mammalian response to ionizing radiation potential applications in oncology
Haus, E. L. (2002) · Chronobiology International · doi:10.1081/cbi-120002592 · Cited by 63
IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation.
Neta, R., Stiefel, S., Finkelman, F. D., HERRMANN, S. H., & Ali, N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4230 · Cited by 62
Brash, D. E. (1996) · Nature Medicine · doi:10.1038/nm0596-525 · Cited by 62
Weichselbaum, R. R., EPSTEIN, J., & Little, J. B. (1976) · Radiology · doi:10.1148/121.2.479 · Cited by 58
The challenge of p53 as prognostic and predictive factor in gliomas
Nieder, C., Petersen, S., Petersen, C., & Thames, H. D. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0145 · Cited by 56
p53 Deficiency Sensitizes Clonogenic Cells to Irradiation in the Large but Not the Small Intestine
Hendry, J. H., Cai, W. B., Roberts, S. A., & Potten, C. S. (1997) · Radiation Research · doi:10.2307/3579610 · Cited by 54
Apoptosis: mediator or mode of cell killing by anticancer agents?
Brown, J. M., & Wouters, B. G. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0193 · Cited by 51
Transfection of Rat Embryo Cells with Mutant p53 Increases the Intrinsic Radiation Resistance
Pardo, F. S., Su, M., Borek, C. G., Preffer, F. I., Dombkowski, D., Gerweck, L. E., & Schmidt, E. V. (1994) · Radiation Research · doi:10.2307/3578901 · Cited by 50
Could p53 be a target for therapeutic suppression?
Komarova, E., & Gudkov, A. V. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0101 · Cited by 50
Self-citationIonizing radiation as a response‐enhancing agent for CD95‐mediated apoptosis
Sheard, M. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1020 · Cited by 44
Disorders of DNA replication and repair
Auerbach, A. D., & Verlander, P. C. (1997) · Current Opinion in Pediatrics · doi:10.1097/00008480-199712000-00010 · Cited by 42
Converting p53 from a killer into a healer
Gudkov, A. V. (2002) · Nature Medicine · doi:10.1038/nm1102-1196 · Cited by 42
Self-citationRole of Retinoblastoma Tumor Suppressor Protein in DNA Damage Response
Wang, S. N. J. Y. J. (2001) · Acta Oncologica · doi:10.1080/02841860152619098 · Cited by 42
DNA repair disorders Commentary
Woods, C. G. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.2.178 · Cited by 40
Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
Frenkel, J., Sherman, D., Fein, A., Schwartz, D., Almog, N., Kapon, A., Goldfinger, N., & Rotter, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202518 · Cited by 39
Gamma-Ray-Induced Cell Killing and Chromosome Abnormalities in the Bone Marrow of p53-Deficient Mice
Wang, L., Cui, Y., Lord, B. I., Roberts, S. A., Potten, C. S., Hendry, J. H., & Scott, D. (1996) · Radiation Research · doi:10.2307/3579455 · Cited by 38
Delayed DNA damage associated with mitotic catastrophe following X-irradiation of HeLa S3 cells*
Ianzini, F., & Mackey, M. A. (1998) · Mutagenesis · doi:10.1093/mutage/13.4.337 · Cited by 36
P53 deficiency produces fewer regenerating spermatogenic tubules after irradiation
J. H. HENDRY, A. A. (1996) · International Journal of Radiation Biology · doi:10.1080/095530096144563 · Cited by 33
Cell Cycle Checkpoints and Cancer
Bártek, J. (2002) · Leukemia · doi:10.1038/sj.leu.2402380 · Cited by 30
DiBiase, S. J., Guan, J., Curran, W. J., & Iliakis, G. E. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00229-1 · Cited by 28
Uberti, D. L., Schwartz, D., Almog, N., Goldfinger, N., Harmelin, A., Memo, M., & Rotter, V. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4606 · Cited by 20
Newmeyer, D. D., & Green, D. R. (1998) · Neuron · doi:10.1016/s0896-6273(00)80580-2 · Cited by 18
The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs
Palacios, C., del Arroyo, A. G., Silva, A., & Collins, M. K. (2000) · Oncogene · doi:10.1038/sj.onc.1203683 · Cited by 17
Rojas, A., & Denekamp, J. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01990451 · Cited by 9
Cellular Responses to DNA Damage and Human Chromosome Instability Syndromes
Khanna, K. K., Gatti, R. A., CONCANNON, P. J., Weemaes, C. M. R., Hoekstra, M. F., Lavin, M. F., & D’Andrea, A. D. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-455-9_19 · Cited by 8
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
The role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Burdelya, L. G., Krivokrysenko, V. I., Tallant, T. C., Strom, E., Gleiberman, A. S., Gupta, D., Kurnasov, O. V., Fort, F. L., Osterman, A. L., DiDonato, J. A., et al. (2008) · Science · doi:10.1126/science.1154986 · Cited by 705
Self-citation
Metadata
- Authors
- Gudkov, A. V., & Komarova, E. A.
- Venue
- Nature Reviews Cancer
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 117-129
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2040881358
- Cited by
- 572
- References
- 120
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.